America's Crucial 10: No-Nonsense Daily News Briefing

President Trump just announced a pilot program that will have Medicare cover weight-loss drugs for the first time. Starting July first, a fifty-dollar copay gets seniors access to drugs that can cost over one thousand dollars a month out of pocket. It's a temporary fix, called the GLP-1 Bridge, but it marks a fundamental shift in U.S. healthcare policy. We focus on the signal, not the noise. Here are the other developments that matter today. The White House has confirmed President Trump will meet with Chinese President Xi Jinping in Beijing next week. It’s the first U.S. presidential visit in nearly a decade, aimed at stabilizing a relationship under severe strain.

The U.S. economy added one hundred fifteen thousand jobs in April. That number is nearly double what was expected, though the unemployment rate held steady at four-point-three percent. Negotiations have restarted for a massive five hundred-jet order for Boeing's 737 MAX from China. The deal was previously stalled by U.S. threats to restrict critical engine parts. Ahead of the summit, Washington is pushing for a concrete commitment from Beijing: the purchase of twenty-five million metric tons of American soybeans annually, plus more poultry and beef. In a sharp statement, Chinese Foreign Minister Wang Yi called Taiwan the "biggest point of risk" in the relationship.

The comment signals Beijing will press for a shift in U.S. diplomatic language. The ongoing war in Iran is complicating the summit agenda. The U.S. Treasury is pressing China to help reopen the Strait of Hormuz, but Beijing has publicly stated that ending the conflict is Washington's responsibility. Bank of America has broken with consensus, forecasting two-point-four percent GDP growth for the U.S. this year. The bank credits AI-driven productivity for its optimism, dismissing widespread recession fears. A key sticking point for the summit has emerged. The U.S. is demanding China lift export controls on rare earth minerals as a precondition for any easing of U.S.

curbs on advanced semiconductors. And finally, a detail buried in the jobs report. Quiet revisions by the Bureau of Labor Statistics have now erased nearly one million jobs from headline reports over the past two years, raising questions about the true strength of the labor market. Let’s go deeper on two of those stories. First, the Medicare decision. For years, Medicare has been explicitly forbidden from covering GLP-1 drugs like Wegovy and Zepbound for weight loss. That left millions of seniors facing costs of twelve thousand dollars a year or more. This new "Bridge" program changes that overnight. The pilot program runs from July first of this year through the end of 2027.

It allows any Medicare Part D recipient with a BMI of twenty-seven or higher to get these drugs for a fifty-dollar copay. This is a major policy experiment. The administration is betting that the long-term health benefits—and cost savings—of treating obesity will outweigh the massive upfront expense. But the program is temporary. It creates a new political reality, and a new political cliff, at the end of next year. Now, to Beijing. The Trump-Xi summit is being framed as a mission to stabilize relations, and that language is precise. No one on either side expects a major breakthrough. The real goal is to stop things from getting worse.

Consider the demands. The U.S. wants soybean quotas and an open Strait of Hormuz. China wants access to high-end American semiconductors and for the U.S. to change its posture on Taiwan. These are foundational conflicts of interest, not minor trade irritants. The Boeing deal for five hundred jets is the perfect illustration of the dynamic: a massive, mutually beneficial commercial transaction held hostage by intractable national security disputes. The backdrop to all of this is a quiet erosion of trust. Beijing just sanctioned U.S. refineries over Iranian oil and is investigating foreign firms for moving supply chains out of China.

Washington is holding firm on tech restrictions. So this summit isn't about finding a solution. It's about finding a floor. The meeting itself is the main deliverable—a signal that both sides have decided the relationship is too important to completely abandon. The day's two biggest stories are about building bridges. One is a temporary pilot program to solve a healthcare crisis. The other is a high-stakes meeting to manage a geopolitical one. Both are attempts to put a floor under a problem that isn't going away. They are acts of maintenance, not transformation.